Trans-dimethyl (2S,3S)-2-formyl-3-[(E)-prop-1-enyl]cyclopropane-1,1-dicarboxylate
C11H14O5 — CID 134962433
Data last refreshed: (MolForge compound catalog, from PubChem)
About Trans-dimethyl (2S,3S)-2-formyl-3-[(E)-prop-1-enyl]cyclopropane-1,1-dicarboxylate
Trans-dimethyl (2S,3S)-2-formyl-3-[(E)-prop-1-enyl]cyclopropane-1,1-dicarboxylate (PubChem CID 134962433) has the molecular formula C11H14O5 and a molecular weight of 226.23 g/mol. Its IUPAC name is trans-dimethyl (2S,3S)-2-formyl-3-[(E)-prop-1-enyl]cyclopropane-1,1-dicarboxylate.
Molecular Properties
| Compound Name | Trans-dimethyl (2S,3S)-2-formyl-3-[(E)-prop-1-enyl]cyclopropane-1,1-dicarboxylate |
|---|---|
| PubChem CID | 134962433 |
| Molecular Formula | C11H14O5 |
| Molecular Weight | 226.23 g/mol |
| Exact Mass | 226.08 |
| IUPAC Name | trans-dimethyl (2S,3S)-2-formyl-3-[(E)-prop-1-enyl]cyclopropane-1,1-dicarboxylate |
| SMILES | C/C=C/[C@H]1[C@H](C=O)C1(C(=O)OC)C(=O)OC |
| InChI | InChI=1S/C11H14O5/c1-4-5-7-8(6-12)11(7,9(13)15-2)10(14)16-3/h4-8H,1-3H3/b5-4+/t7-,8-/m0/s1 |
| InChIKey | FHEVGJPIHYNHFD-VEVSIANRSA-N |
| XLogP | 0.34 |
| TPSA | 69.67 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 16 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 226.23 |
| LogP ≤ 5 | 0.34 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134962433 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.